Rajeev Mishra
Chhatrapati Shahu Ji Maharaj University, Manipal University - Jaipur Campus, Central Drug Research Institute, Cedars-Sinai Medical Center
About
Dr Rajeev Mishra is Associate Professor in the Department of Life Sciences & Biotechnology at CSJM University, Kanpur, India from 2022. Earlier Dr Mishra was working As Assistant Professor at Manipal University Jaipur, India. Dr Mishra, prior to Joining Manipal University Jaipur, was Project Scientist at Samuel Oschin Cancer Center,
Cedars Sinai Medical Center, Los Angeles, California, USA. He has more
than 16 years of experience in cancer drug discovery research and
therapeutic resistance. He obtained his Ph.D. from Central Drug Research
Institute, Lucknow and CSJM University, Kanpur, India. After finishing
Ph.D. in 2007, he joined Department of Cancer Genetics, Nihon University
School of Medicine, Tokyo, Japan as the post-doctoral fellow. In 2011, he
joined Department of Medicine at Samuel Oschin Cancer Center, Cedars
Sinai Medical Center, Los Angeles, California, USA, as post doctoral
scientist. Dr Mishra has published several research papers in almost all top
cancer journals either as a first or co-author, which include Cancer Cell,
Oncogene, Cancer Research, Cancer Science and Journal of Clinical
Investigation. He has made significant contributions in the area of
regulation of gene expression and its link to disease and therapeutics. He is
not only elucidating the mechanisms of transcription regulation through
the epigenetic modifications, but also targeting them to design new
generation diagnostics, as well as therapeutics.
Employment
-
Chhatrapati Shahu Ji Maharaj University Associate Professor2022 - Present
-
Manipal University - Jaipur Campus Assistant Professor2018 - 2022
-
Cedars-Sinai Medical Center Scientist2011 - 2018
-
Nihon University Post-Doctoral Fellow2007 - 2011
Education
-
Central Drug Research Institute Doctrate2002 - 2007
Projects & Funding
Projects & funding information is unavailable.
Publications (44)
- In-Silico CLEC5A mRNA expression analysis to predict Dengue susceptibility in cancer patients Save
- In silico prediction of COVID-19 cytokine storm in lung cancer types Save
- TGF-β controls stromal telomere length through epigenetic modifications Save
- Harnessing the Role of Epigenetic Histone Modification in Targeting Head and Neck Squamous Cell Carcinoma Save
- DNA biosensor based detection for neglected tropical disease: moving towards smart diagnosis Save
- Therapeutic effects of CoenzymeQ10, Biochanin A and Phloretin against arsenic and chromium induced oxidative stress in mouse (Mus musculus) brain Save
- Shelterin complex gene: Prognosis and therapeutic vulnerability in cancer Save
- A comprehensive study to fabricate NAC loaded PLGA nanoparticles for drug delivery Save
- Epigenetic modulation by biosynthetic nanomaterials from plants in cancer Save
- Saponins: Extraction, bio-medicinal properties and way forward to anti-viral representatives Save